Scientific Research

Brain organoids have revolutionized our ability to study human neurological diseases. These 3D models recapitulate key features of brain development and enable research previously impossible with animal models.

Alzheimer's Disease

Patient-derived organoids modeling amyloid plaque formation and tau pathology for drug screening.

Parkinson's Disease

Dopaminergic neuron models for neuroprotective compound testing and disease mechanism studies.

Glioblastoma

Patient tumor organoids for personalized chemotherapy sensitivity testing.

Zika Virus

Infection models demonstrating viral impacts on developing brain tissue.

Drug-induced liver injury (DILI) remains a leading cause of drug failure and withdrawal. Human liver models provide superior prediction of hepatotoxicity compared to animal testing.

DILI Prediction

Multi-parameter assessment of hepatotoxicity risk using liver-on-chip systems.

NASH Modeling

Non-alcoholic steatohepatitis models for metabolic liver disease therapeutics.

Drug Metabolism

CYP450 enzyme activity and drug-drug interaction prediction.

Cardiotoxicity is the second leading cause of drug withdrawal. Human heart models detect arrhythmia risks that animal models miss, improving drug safety assessment.